Graviton Bioscience

New York, United States

Biotechnology, clinical stage, CNC, autoimmune, fibrotic indications

$25.0M raised

Jan 2024

Private Equity

Biotechnology Therapeutics

Top Investors

Sanofi Enavate Sciences Pontifax

Founder Contacts

30,000+ verified contacts

Get Instant Access

Emails, phones & LinkedIn profiles

Frequently Asked Questions about Graviton Bioscience

How much funding has Graviton Bioscience raised?

Graviton Bioscience has raised $25.0M in total funding. The most recent round was Private Equity. The last funding was announced in January 2024.

Who are Graviton Bioscience's investors?

Graviton Bioscience's investors include Sanofi, Enavate Sciences, Pontifax.

Where is Graviton Bioscience headquartered?

Graviton Bioscience is headquartered in New York, United States.

What does Graviton Bioscience do?

Biotechnology, clinical stage, CNC, autoimmune, fibrotic indications

What stage is Graviton Bioscience at?

Graviton Bioscience is at the Private Equity stage.

Cite this page

Free to use in articles, research, and reference works. Stable URL — will not change. Data on this page last updated January 2, 2024.

MLA

"Graviton Bioscience — Funding & Investors." VCBacked, January 2, 2024, https://www.vcbacked.co/company/graviton-bioscience. Accessed July 2, 2026.

APA

VCBacked. (2024). Graviton Bioscience — Funding & Investors. Retrieved July 2, 2026, from https://www.vcbacked.co/company/graviton-bioscience

Wikipedia (cite web)

{{cite web |title=Graviton Bioscience — Funding & Investors |url=https://www.vcbacked.co/company/graviton-bioscience |website=VCBacked |access-date=July 2, 2026}}

Profile data sourced and verified per the VCBacked methodology. Last funding round dated January 2, 2024.

Similar Companies in Biotechnology

View all

Renaissance BioScience

Vancouver$599K

Allterum Therapeutics

Advanced Microbiome Interventions

Amsterdam$300K